feed,title,long_url,short_url
Investors,"Alnylam Plummets, Reversing 50% Gain This Year, As Pfizer Rival Lags Expectations",https://www.investors.com/news/technology/alnylam-stock-plummets-vutrisiran-cardiomyopathy/,https://da.gd/hc7HB
